Lot certificates published
Plain, secure packaging

Compound monograph

Epitalon

Epitalon is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, described in the source literature as a short peptide designed following work on pineal tissue extracts.

Published: 2026-09-04Last updated: 2026-10-16Literature/identifier verification: 2026-08-23
Also known asEpithalonEpithaloneAEDG peptide

01

Identity & nomenclature

Epitalon is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, described in the source literature as a short peptide designed following work on pineal tissue extracts.

Epitalon, Epithalon, and Epithalone all refer to the same tetrapeptide. A second registry number, 64082-79-7, also appears in the PubChem record; 307297-39-8 is carried here as primary. The literature describes the peptide as having been designed following work on a pineal extract preparation named Epithalamin, from which the name derives.

Declared aliases and development codes: Epithalon, Epithalone, AEDG peptide.

02

Molecular properties

Molecular formulaC14H22N4O9
Molecular mass390.35 Da
CAS Registry Number307297-39-8
PubChem CID219042
UNIIO65P17785G
One-letter sequenceAEDG
Three-letter sequenceAla–Glu–Asp–Gly
Terminal groupsFree N-terminus; Free C-terminal carboxyl

Tetrapeptide Ala-Glu-Asp-Gly, stated identically in the PubChem synonym record and in the source literature.

03

Structural characteristics

The sequence comprises four proteinogenic residues with no reported terminal modification in the PubChem record. Two of the four side chains are acidic, giving the peptide a low isoelectric point relative to neutral tetrapeptides.

Terminal features: Free N-terminus, Free C-terminal carboxyl.

04

Molecular targets & mechanisms

05

Analytical considerations

At 390 Da this is among the smallest peptides in the catalog, and it contains no aromatic residues, so UV detection at 280 nm gives no useful chromophore response. Identity confirmation relies on mass and sequence-level methods.

Disagreements and mix-ups

Points where sources disagree about this compound's identity, or where a name or form is easily confused with another, as noted in this record. The discrepancy register quotes the passage for each one.

What the studies reported

Each finding describes one cited study in its stated model. These observations are specific to that study and do not establish effects in other settings.

Cell and tissue studies

  • Telomerase-negative human fetal fibroblast culture

    Khavinson et al. reported expression of the telomerase catalytic subunit and telomerase enzymatic activity after adding Epithalon to telomerase-negative human fetal fibroblast culture.

    Reference [3]
  • Telomerase-negative human fetal fibroblast culture

    Khavinson et al. reported telomere elongation after adding Epithalon to telomerase-negative human fetal fibroblast culture.

    Reference [3]

06

Verified bibliography

Cited studies by type

The 3 papers this record cites, counted by the kind of work each reports. A count is the size of this record's selection, not of the research that exists, and says nothing about results, safety, effectiveness or approval.

A paper can report more than one kind of work. Each count opens those papers in the bibliography. Compare every record on the Evidence Map.

  1. Reference 1

    Peptides and Ageing.

    Khavinson VKh

    Neuro endocrinology letters · 2002 · Review

    current
  2. Reference 2

    Peptide Regulation of Cell Differentiation.

    Khavinson V, Linkova N, Diatlova A, Trofimova S

    Stem cell reviews and reports · 2020-02 · Review

    current
  3. Reference 3

    Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.

    Khavinson VKh, Bondarev IE, Butyugov AA

    Bulletin of experimental biology and medicine · 2003-06 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Khavinson VKh 2002Review article
Khavinson V et al. 2020Review article
Khavinson VKh et al. 2003Study models reported: in vitro · from the abstract

Catalog listing

Record history

Published 2026-09-04.

  • : References
  • : Sequence and structure
  • : Identity and nomenclature

Each entry names the parts of this record that changed on that date. Changes to links between records and to catalogue links are not listed. This history covers the tracked record fields; study findings are not listed here.

Cite this record: Purely Peptides Research Library. Epitalon. Published 2026-09-04; updated 2026-10-16. https://purelypeptides.org/research/compounds/epitalon/

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →